Abstract
There is some recent evidence that the coronavirus disease 2019 (COVID-19) increases the risk of venous thromboembolism by creating a prothrombotic state. COVID-19 and pulmonary embolism (PE) are both associated with tachypnoea, hypoxemia, dyspnoea, and increased D-dimer. Diagnosis of pulmonary embolism in a patient with COVID-19 compared to an individual without it, using the conventional clinical and biochemical evidence is challenging and somehow impossible. In this study, we reported four male cases affected by COVID-19 and admitted to hospitals in Sanandaj, Iran. The patients were all older adults (ranging between 56 and 95 years of age). Fever, chills, muscle pain, and cough were evident in all the cases. Red blood cell levels were low, and pulmonary embolism was clearly detected on spiral computed tomographic (CT) angiography of the pulmonary circulation of all patients. These cases demonstrated that COVID-19 may lead to pulmonary embolism by causing blood coagulation problems. As COVID-19 continues to cause considerable mortality, more information is emerging which reveals its complicated pathogenicity. In the meantime, venous thromboembolism remains an uncommon finding in patients with COVID-19. It is essential that he...Continue Reading
References
Feb 24, 2016·JAMA : the Journal of the American Medical Association·Mervyn SingerDerek C Angus
Aug 15, 2019·Journal of Thrombosis and Haemostasis : JTH·Toshiaki IbaUNKNOWN Scientific and Standardization Committee on DIC, and the Scientific and Standardization Committee on Perioperative and Criti
Jan 5, 2020·Journal of Medical Case Reports·Lindsay WarnerJason Eldrige
Feb 1, 2020·Radiology·Junqiang LeiXiaolong Qi
Feb 3, 2020·Lancet·Nanshan ChenLi Zhang
Feb 6, 2020·Radiology·Michael ChungHong Shan
Feb 8, 2020·JAMA : the Journal of the American Medical Association·Dawei WangZhiyong Peng
Feb 20, 2020·Journal of Thrombosis and Haemostasis : JTH·Ning TangZiyong Sun
Feb 29, 2020·The New England Journal of Medicine·Wei-Jie GuanUNKNOWN China Medical Treatment Expert Group for Covid-19
Mar 15, 2020·Lancet·Fei ZhouBin Cao
Mar 17, 2020·Clinical Chemistry and Laboratory Medicine : CCLM·Huan HanCheng-Liang Zhu
Mar 29, 2020·Journal of Thrombosis and Haemostasis : JTH·Ning TangZiyong Sun
Apr 13, 2020·The Lancet. Haematology·Tao WangShiyue Li
Apr 16, 2020·Thrombosis Research·F A KlokH Endeman
Apr 20, 2020·Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology·Dimitrios GiannisPanagiota Gianni
Apr 21, 2020·Journal of the American College of Cardiology·Behnood BikdeliUNKNOWN Global COVID-19 Thrombosis Collaborative Group, Endorsed by the ISTH, NATF, ESVM, and the IUA, Supported by the ESC Working
May 1, 2020·Bioscience Trends·Ying ZouZhiping Qian
May 1, 2020·European Heart Journal. Cardiovascular Pharmacotherapy·Bassam AtallahWael AlMahmeed
May 1, 2020·Thrombosis Research·Corrado LodigianiUNKNOWN Humanitas COVID-19 Task Force
May 6, 2020·Intensive Care Medicine·Julie HelmsUNKNOWN CRICS TRIGGERSEP Group (Clinical Research in Intensive Care and Sepsis Trial Group for Global Evaluation and Research in Sep
May 6, 2020·Journal of Thrombosis and Haemostasis : JTH·Saskia MiddeldorpNick van Es
May 10, 2020·Thrombosis Research·F A KlokH Endeman
Jun 20, 2020·Archives of Pathology & Laboratory Medicine·Yang FeiWenjing Cao
Jul 21, 2020·Respirology Case Reports·Yuto AkiyamaKoichi Fukunaga
Sep 15, 2020·Clinical Practice and Cases in Emergency Medicine·James Greenan-Barrett, Adrian Perera
Sep 22, 2020·Annals of Intensive Care·Yasser SakrElio Antonucci